Inhibitors of the bone morphogenetic protein (BMP) signaling pathway: a patent review (2008-2015)

References

• Wang RN, Green J, Wang Z, et al. Bone morphogenetic protein (BMP) signaling in development and human diseases. Genes Dis. 2014;1(1):87–105.
   PubMedGoogle Scholar
• Brazil DP, Church RH, Surae S, et al. BMP signalling: agony an atagony in the family. Trends Cell Biol. 2015;25(5):249–264.
   PubMed Web of Science ®Google Scholar
• Rosen V. BMP and BMP inhibitors in bone. Ann N Y Acad Sci. 2006;1068:19–25.
   PubMed Web of Science ®Google Scholar
• Liu A, Niswander LA. Bone morphogenetic protein signaling and vertebrate nervous system development. Nat Rev Neurosci. 2005;6:945–954.
   PubMed Web of Science ®Google Scholar
• Sieber C, Kopf J, Hieben C, et al. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. 2009;20(5–6):343–355.
   PubMed Web of Science ®Google Scholar
• Fuji M, Takeda K, Imamura T, et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell. 1999;10(11):3801–3813.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang R, Chen D, et al. Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation. J Cell Physiol. 2012;227(3):952–963.
   PubMed Web of Science ®Google Scholar
• Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–1023.
   PubMed Web of Science ®Google Scholar
• Yu PB, Hong CC, Sachidanandan C, et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 2008;4:33–41.
   PubMed Web of Science ®Google Scholar
• Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38(5):525–527.
   PubMed Web of Science ®Google Scholar
• Hong CC, Yu PB. Applications of small molecule BMP inhibitors in physiology and disease. Cytokine Growth Factor Rev. 2009;20:409–418.
   PubMed Web of Science ®Google Scholar
• Waite KA, Eng C. From developmental disorder to heritable cancer: it’s all in the BMP/TGF-beta family. Nat Rev Genet. 2003;4:763–773.
   PubMed Web of Science ®Google Scholar
• Wrighton KH, Lin X, Yu PB, et al. Transforming growth factor-beta can stimulate Smad1 phosphorylation independently of bone morphogenetic protein receptors. J Biol Chem. 2009;284(15):9755–9763.
   PubMed Web of Science ®Google Scholar
• Owens P, Pickup MW, Novitskiy SV, et al. Inhibition of BMP signaling suppresses metastasis in mammary cancer. Oncogene. 2015;34(19):2437–2449.
   PubMed Web of Science ®Google Scholar
• Owens P, Polikowsky H, Pickup MW, et al. Bone morphogenetic proteins stimulate mammary fibroblasts to promote mammary carcinoma cell invasion. PloS One. 2013;8:e67533.
   PubMed Web of Science ®Google Scholar
• Tsai CL, Tsai CN, Lin C-Y, et al. Secreted stress-induced phosphoprotein 1 activates the ALK2-SMAD signaling pathways and promotes cell proliferation of ovarian cancer cells. Cell Rep. 2012;2(2):283–293.
   PubMed Web of Science ®Google Scholar
• Hover LD, Young CD, Bhola NE, et al. Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth. Cancer Lett. 2015;368(1):79–87.
   PubMed Web of Science ®Google Scholar
• Taylor KR, Mackay A, Truffaux N, et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet. 2014;46(5):457–461.
   PubMed Web of Science ®Google Scholar
• Wu G, Diaz AK, Paugh BS, et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet. 2014;46(5):444–450.
   PubMed Web of Science ®Google Scholar
• Laperrousaz B, Jeanpierre S, Sagorny K, et al. Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression. Blood. 2013;122(23):3767–3777.
   PubMed Web of Science ®Google Scholar
• Toofan P, Irvine D, Hopcroft L, et al. The role of the bone morphogenetic proteins in leukaemic stem cell persistence. Biochem Soc Trans. 2014;42:809–815.
   PubMed Web of Science ®Google Scholar
• Choi K-C, Lee YS, Lim S, et al. Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol. 2006;7:1057–1065.
   PubMed Web of Science ®Google Scholar
• Derwall M, Malhotra R, Lai CS, et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:613–622.
   PubMed Web of Science ®Google Scholar
• Yu PB, Deng DY, Lai CS, et al. BMP type I receptor inhibition reduces heterotopic ossification. Nat Med. 2008;14(12):1363–1369.
   PubMed Web of Science ®Google Scholar
• Luu HH, Song W-X, Luo X, et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 2007;25(5):665–677.
   PubMed Web of Science ®Google Scholar
• Cuny GD, Yu PB, Laha JK, et al. Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg Med Chem Lett. 2008;18:4388–4392.
   PubMed Web of Science ®Google Scholar
• Hao J, Ho JN, Lewis JA, et al. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol. 2010;5(2):245–253.
   PubMed Web of Science ®Google Scholar
• Neely MD, Litt MJ, Tidball AM, et al. DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction. ACS Chem Neurosci. 2012;3(6):482–491.
   PubMed Web of Science ®Google Scholar
• Hao J, Lee R, Chang A, et al. DMH1, a small molecule inhibitor of BMP type I receptors, suppresses growth and invasion of lung cancer. PLoS ONE. 2014;9(3):e90748.
   PubMed Web of Science ®Google Scholar
• Ao A, Hao J, Hopkins CR, et al. DMH1, a novel BMP small molecule inhibitor, increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells. PLoS ONE. 2012;7(7):e41627.
   PubMed Web of Science ®Google Scholar
• Hover LD, Owens P, Munden AL, et al. Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma. Neuro Oncol. 2016;18(7);928–938.
   PubMed Web of Science ®Google Scholar
• Mohedas AH, Xing X, Armstrong KA, et al. Development of an ALK2-biased BMP type I receptor kinase inhibitor. ACS Chem Biol. 2013;8(6):1291–1302.
   PubMed Web of Science ®Google Scholar
• Engers DW, Frist AY, Lindsley CW, et al. Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from pyrazolo[1,5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Bioorg Med Chem Lett. 2013;23:3248–3252.
   PubMed Web of Science ®Google Scholar
• Mohedas AH, Wang Y, Sanvitale CE, et al. Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans pogressiva causing mutants. J Med Chem. 2014;57(19):7900–7915.
   PubMed Web of Science ®Google Scholar
• Sanvitale CE, Kerr G, Chaikuad A, et al. A new class of small molecule inhibitor of BMP signaling. PLoS ONE. 2013;8(4):e62721.
   PubMed Web of Science ®Google Scholar
• Yu PB, Hong CC, Bloch KD, et al. Methods for identifying compounds that modulate cell signaling and methods employing such compounds. WO2008/033408. 2008.
   Google Scholar
• Yu PB, Cuny GD, Bloch KD, et al. Inhibitors of the BMP signaling pathway. WO2009114180. 2009.
   Google Scholar
• Yu PB, Derwall M, Bloch KD, et al. Compositions and methods for cardiovascular disease. WO2012100229. 2012.
   Google Scholar
• Yu PB, Cuny GD, Mohedas AH, et al. BMP inhibitors and methods of use thereof. WO2014138088. 2014.
   Google Scholar
• Alimardanov A, Cuny GD, Grewal GS, et al. BMP inhibitors and methods of use thereof. WO2014160203. 2014.
   Google Scholar
• Lee A, McKew JC, Patel PR, et al. Compositions and methods for inhibiting BMP. WO2016011019. 2016.
   Google Scholar
• Yu PB, Cuny GD, Mohedas AH. Compositions and methods for inhibiting BMP. WO2015148654. 2015.
   Google Scholar
• Hong CC, Hopkins CR, Hatzopoulos AK, et al. Compounds and methods useful for directing stem cell differentiation. US 8,822,684. 2014.
   Google Scholar
• Hopkins CR, Hong CC, Lindsley CW, et al. Fused heterocyclic compounds as selective BMP inhibitors. WO2014051698. 2014.
   Google Scholar